molecules
Review
Recent Advances in the Synthesis of β-Carboline Alkaloids
Tímea Szabó , Balázs Volk and Mátyás Milen *
Citation: Szabó, T.; Volk, B.; Milen,
M. Recent Advances in the Synthesis
of β-Carboline Alkaloids. Molecules
2021, 26, 663. https://doi.org/
10.3390/molecules26030663
Academic Editors: György Szöllösi
and Eva Frank
Received: 13 November 2020
Accepted: 21 January 2021
Published: 27 January 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Egis Pharmaceuticals Plc., Directorate of Drug Substance Development, P.O. Box 100, H-1475 Budapest, Hungary;
szabo.timea91@gmail.com (T.S.); volk.balazs@egis.hu (B.V.)
* Correspondence: milen.matyas@egis.hu; Tel.: +36-1-8035-874
Abstract: β-Carboline alkaloids are a remarkable family of natural and synthetic indole-containing
heterocyclic compounds and they are widely distributed in nature. Recently, these alkaloids have
been in the focus of interest, thanks to their diverse biological activities. Their pharmacological
activity makes them desirable as sedative, anxiolytic, hypnotic, anticonvulsant, antitumor, antiviral,
antiparasitic or antimicrobial drug candidates. The growing potential inherent in them encourages
many researchers to address the challenges of the synthesis of natural products containing complex
β-carboline frameworks. In this review, we describe the recent developments in the synthesis of
β-carboline alkaloids and closely related derivatives through selected examples from the last 5 years.
The focus is on the key steps with improved procedures and synthetic approaches. Furthermore the
pharmacological potential of the alkaloids is also highlighted.
Keywords: β-carboline; natural products; total synthesis; bioactive molecules
1. Introduction
Carbolines are a remarkable family of heterocyclic natural products, with outstanding
pharmacological potential. They are determined by their tricyclic, pyridine-fused indole
framework (where the rings are identified as A, B and C), and classified according to the
degree of saturation (fully saturated: 1,2,3,4-tetrahydro; partially saturated: 3,4-dihydro;
and unsaturated β-carbolines) and the position of the N-atom in the C-ring as α-, β-, γ-
or δ-carbolines (Figure 1)[1,2]. β-Carboline alkaloids are widely distributed in nature
including various plants, foodstuffs, marine creatures, insects, mammals as well as human
tissues and body fluids. Numerous representatives of this family show various biological
activities [3–5]. The fascinating diversity of structures and medicinal potential [6] inherent
in them encourage several researchers to deal with the synthesis of β-carboline containing
natural products and their synthetic derivatives [2,4,7–9]. Several commercial drugs or drug
candidates such as vinpocetine, brovincamine, abecarnil, cipargamin, tadalafil, reserpine
and lurbinectedin contain this unique framework (Figure 1).
This review focuses on the field of β-carboline research through selected examples
from the last 5 years, where the key information on natural occurrence, structural diversity
and biological activities is highlighted (Table 1). The comprehensive demonstration of
recent advances in the synthesis of naturally occurring β-carbolines, including both simple
β-carbolines (Section 2 of this review) and fused ring systems containing this framework
(see Figure 1 and Section 3 of this review), is discussed with a special emphasis on the
innovative framework construction steps.
Molecules 2021, 26, 663. https://doi.org/10.3390/molecules26030663 https://www.mdpi.com/journal/molecules